Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model
Jea‐Young Lee, Julian P. Tuazon, Jared Ehrhart, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 8, pp. 5466-5474
Open Access | Times Cited: 24

Showing 24 citing articles:

Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
Vanessa Castelli, Michele d’Angelo, Francesca Lombardi, et al.
Aging (2020) Vol. 12, Iss. 5, pp. 4641-4659
Open Access | Times Cited: 127
Challenges in the clinical advancement of cell therapies for Parkinson’s disease
Sophie Skidmore, Roger A. Barker
Nature Biomedical Engineering (2023) Vol. 7, Iss. 4, pp. 370-386
Open Access | Times Cited: 22
Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI Improves Cognitive and Memory Function in the Mouse Model of Alzheimer’s Disease
Hongwon Kim, Kim Su-Min, Sang-jun Park, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 48
Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms
Z. Sun, Ping Gu, Hongjun Xu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 36
Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
Justin Cho, You Jeong Park, Bella Gonzales‐Portillo, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 5, pp. 505-514
Open Access | Times Cited: 37
Convergence of Neuroinflammation, Microbiota, and Parkinson’s Disease: Therapeutic Insights and Prospects
Nerea Domínguez Rojo, Mercedes Blanco Benítez, Ramón Cava, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 4
A gut feeling about stroke reveals gut-brain axis’ active role in homeostasis and dysbiosis
Brooke Bonsack, Rays H. Y. Jiang, Cesar V. Borlongan
Journal of Cerebral Blood Flow & Metabolism (2020) Vol. 40, Iss. 5, pp. 1132-1134
Open Access | Times Cited: 25
Using multi-organ culture systems to study Parkinson’s disease
Orly Reiner, Tamar Sapir, Arpan Parichha
Molecular Psychiatry (2020) Vol. 26, Iss. 3, pp. 725-735
Open Access | Times Cited: 25
Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats
Linna Zhao, Song-Wen Ma, Jie Xiao, et al.
World Journal of Stem Cells (2021) Vol. 13, Iss. 12, pp. 1905-1917
Open Access | Times Cited: 21
Probiotic Formulation VSL#3 Interacts with Mesenchymal Stromal Cells To Protect Dopaminergic Neurons via Centrally and Peripherally Suppressing NOD-Like Receptor Protein 3 Inflammasome-Mediated Inflammation in Parkinson’s Disease Mice
Liping Zhou, Deqiang Han, Xingzhe Wang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
Changwei Yang, Tingting Zhang, Wuqiong Wang, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 21
Parkinson’s Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration
Georgia Xiromerisiou, Chrysoula Marogianni, Anastasia Androutsopoulou, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 93-93
Open Access | Times Cited: 7
Inflammation-relevant microbiome signature of the stroke brain, gut, spleen, and thymus and the impact of exercise
Chase Kingsbury, Alex Shear, Matt Heyck, et al.
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 12, pp. 3200-3212
Open Access | Times Cited: 17
A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity
Jea-Young Lee, Julian P. Tuazon, Sydney Corey, et al.
Stem Cell Reviews and Reports (2019) Vol. 15, Iss. 5, pp. 690-702
Open Access | Times Cited: 16
Inflammatory gut as a pathologic and therapeutic target in Parkinson’s disease
Jea-Young Lee, Zhen-Jie Wang, Alexa Moscatello, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 8
The Role of The Gut Microbiome in Parkinson’s Disease
Amy Gallop, James Weagley, Saif-ur-Rahman Paracha, et al.
Journal of Geriatric Psychiatry and Neurology (2021) Vol. 34, Iss. 4, pp. 253-262
Closed Access | Times Cited: 10
The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy
Mia C. Borlongan, Maximillian C. Borlongan, Paul R. Sanberg
Cell Transplantation (2020) Vol. 29, pp. 096368972094071-096368972094071
Open Access | Times Cited: 9
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
Jonah Gordon, Gavin Lockard, Molly Monsour, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10138-10138
Open Access | Times Cited: 6
Human Umbilical Cord Blood Serum–derived α-Secretase
Ahsan Habib, Huayan Hou, T. Mori, et al.
Cell Transplantation (2018) Vol. 27, Iss. 3, pp. 438-455
Open Access | Times Cited: 9
Gut Microbiome: Lactation, Childbirth, Lung Dysbiosis, Animal Modeling, Stem Cell Treatment, and CNS Disorders
Sydney Corey, Lauren Kvederis, Chase Kingsbury, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 9, pp. 687-694
Closed Access | Times Cited: 9
Going straight for the gut: gut-brain axis pathology and treatment of Parkinson’s disease
Dominique Ebedes, Cesar V. Borlongan
Neural Regeneration Research (2024)
Open Access
Probing Gut Participation in Parkinson’s Disease Pathology and Treatment via Stem Cell Therapy
Jea-Young Lee, Vanessa Castelli, Paul R. Sanberg, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10600-10600
Open Access | Times Cited: 1
Characteristics of Umbilical-Cord Blood and Its Use in Clinical Practice
A. G. Goncharov, K. А. Yurova, В. В. Шуплецова, et al.
Cell and Tissue Biology (2022) Vol. 16, Iss. 1, pp. 15-31
Closed Access | Times Cited: 2
Potential Treatment of Parkinson's Disease, Using Last-Generation Carbon Nanotubes: A Bimolecular In-Silico Study
Ehsan Alimohammadi, Arash Nikzad, Mohamad Khedri, et al.
Research Square (Research Square) (2020)
Open Access
Page 1

Scroll to top